All Press Releases
Gotion High-Tech Wins Volkswagen Cell Test Lab Qualification
Gotion High-tech Co Ltd
•
Feb 23, 2023 10:55 HKT/SGT
On February 21, Gotion High-tech was officially granted the Volkswagen Cell Test Lab qualification certificate. This certification marks the recognition of Gotion's test capability by Volkswagen and its formal entry into the world-leading technological management system.As one of the world&apos
乐普生物和康诺亚共同宣布与阿斯利康就CMG901达成全球独家授权协议
Lepu Biopharma Co., Ltd.
•
Feb 23, 2023 10:20 HKT/SGT
乐普生物科技股份有限公司 （HK：02157）和康诺亚生物医药科技有限公司（HK：02162）今日共同宣布与阿斯利康（AstraZeneca，LSE/STO/纳斯达克：AZN）就潜在世界首创Claudin 18.2抗体偶联药物CMG901达成全球独家授权协议。根据许可协议，阿斯利康将负责 CMG901 的全球研发、制造和商业化。CMG901正在进行治疗Claudin18.2阳性表达的实体瘤的I期临床试验。I期临床试验的初步结果表明，CMG901具有良好的安全性和耐受性，并在目前临床试验的剂量水平上呈现出令人鼓舞的抗肿瘤疗效。基于此协议及条款，由乐普生物和康诺亚合资设立的KYM Bioscien
樂普生物和康諾亞共同宣佈與阿斯利康就CMG901達成全球獨家授權協定
Lepu Biopharma Co., Ltd.
•
Feb 23, 2023 10:19 HKT/SGT
樂普生物科技股份有限公司 （HK：02157）和康諾亞生物醫藥科技有限公司（HK：02162）今日共同宣佈與阿斯利康（AstraZeneca，LSE/STO/納斯達克：AZN）就潛在世界首創Claudin 18.2抗體偶聯藥物CMG901達成全球獨家授權協定。根據授權合約，阿斯利康將負責 CMG901 的全球研發、製造和商業化。CMG901正在進行治療Claudin18.2陽性表達的實體瘤的I期臨床試驗。I期臨床試驗的初步結果表明，CMG901具有良好的安全性和耐受性，並在目前臨床試驗的劑量水準上呈現出令人鼓舞的抗腫瘤療效。基於此協議及條款，由樂普生物和康諾亞合資設立的KYM Bioscien
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901
Lepu Biopharma Co., Ltd.
•
Feb 23, 2023 10:18 HKT/SGT
On 23 February, 2023, Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) today jointly announces a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudin 18.2 antib
Doubleview Provides Update on Milestone 56% Scandium Phosphate Recovery in First Phase Metallurgical Testing at the HAT Deposit
Doubleview Gold Corp.
•
Feb 22, 2023 23:00 HKT/SGT
Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: 1D4) ("Doubleview") is pleased to provide additional information regarding the metallurgical process and significance of achieving 56% scandium ("Sc") recovery to a scandium phosphate precipitate, in the first attempt of sequ
“巩固复苏动力”
ACN Newswire
•
Feb 22, 2023 20:43 HKT/SGT
香港董事学会认为，今日发表的预算案，着力经济复苏，铺垫数码转型，以高质量发展提升市民生活质素。社会经济需要支持财政司司长指出，经济恢复之际，不少市民及企业仍需支持。预算案公布一次性纾困措施，当中，薪俸税利得税宽减上限额度较往年少，但增加子女免税额可以令不少家庭受惠。预算案咨询期间，社会上确实有不少声音要求再派消费券。司长今日公布，仍向合资格人士分两期派发消费券5千元，大概是平衡了社会要求与财政负担。我们认为，税费宽减或仍可以手松一点支持打工仔中产一族，综援等各项福利津贴或仍可以多派一点去照顾基层。虽然说消费券刺激消费有助经济，但效果可以是将港人的高消费推送到外地去花，肥水先流别人田。我们的预算
“鞏固復蘇動力”
ACN Newswire
•
Feb 22, 2023 20:42 HKT/SGT
香港董事學會認為，今日發表的預算案，著力經濟復蘇，鋪墊數碼轉型，以高質量發展提升市民生活質素。社會經濟需要支援財政司司長指出，經濟恢復之際，不少市民及企業仍需支援。預算案公佈一次性紓困措施，當中，薪俸稅利得稅寬減上限額度較往年少，但增加子女免稅額可以令不少家庭受惠。預算案咨詢期間，社會上確實有不少聲音要求再派消費券。司長今日公佈，仍向合資格人士分兩期派發消費券5千元，大概是平衡了社會訴求與財政負擔。我們認為，稅費寬減或仍可以手鬆一點支援打工仔中產一族，綜援等各項福利津貼或仍可以多派一點去照顧基層。雖然説消費券刺激消費有助經濟，但效果可以是將港人的高消費推送到外地去花，肥水先流別人田。我們的預算
Web 3 streaming platform myco secures rights for HBL PSL 8 cricket coverage across MENA
ACN Newswire
•
Feb 22, 2023 19:49 HKT/SGT
myco (formerly known as MContent), a leading entertainment and sports streaming platform, today announced it will stream the Pakistan Super League (HBL PSL Season 8) through CricLife 2 on its Web 3 streaming platform in the MENA region for free, offering viewers the chance to watch the live stream o
亿胜生物与复宏汉霖签订治疗年龄相关性黄斑变性全球共同开发及独家许可协议之经修订协议
Essex Bio-Technology Limited
•
Feb 22, 2023 18:50 HKT/SGT
亿胜生物科技有限公司（「亿胜生物」或「集团」，股票代码：1061.HK）今日宣布，集团全资附属子公司亿胜生物投资有限公司（「亿胜生物投资」）及珠海亿胜生物制药有限公司（「珠海亿胜」）与上海复宏汉霖生物技术股份有限公司（「复宏汉霖」，股票代码：2696.HK）就2020年10月签订的全球共同开发及独家许可协议（「协议」） 签订一份经修订协议（「经修订协议」）。根据协议，亿胜生物投资和复宏汉霖将共同开发贝伐珠单抗HLX04（「产品」或 「EB12-20145P」），用于治疗湿性年龄相关性黄斑变性（wAMD）等眼科疾病。亿胜生物投资获得该产品在全球范围内针对眼科适应症进行开发、生产及商业化的独家权限
億勝生物與復宏漢霖簽訂治療年齡相關性黃斑變性全球共同開發及獨家許可協議之經修訂協議
Essex Bio-Technology Limited
•
Feb 22, 2023 18:49 HKT/SGT
億勝生物科技有限公司（「億勝生物」或「集團」，股票代碼：1061.HK）今日宣布，集團全資附屬子公司億勝生物投資有限公司（「億勝生物投資」）及珠海億勝生物製藥有限公司（「珠海億勝」）與上海復宏漢霖生物技術股份有限公司（「復宏漢霖」，股票代碼：2696.HK）就2020年10月簽訂的全球共同開發及獨家許可協議（「協議」） 簽訂一份經修訂協議（「經修訂協議」）。根據協議，億勝生物投資和復宏漢霖將共同開發貝伐珠單抗HLX04（「產品」或 「EB12-20145P」），用於治療濕性年齡相關性黃斑變性（wAMD）等眼科疾病。億勝生物投資獲得該產品在全球範圍內針對眼科適應症進行開發、生產及商業化的獨家許可
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration
Essex Bio-Technology Limited
•
Feb 22, 2023 18:48 HKT/SGT
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that two of its wholly-owned subsidiaries, Essex Bio-Investment Limited ("Essex Bio-Investment") and Zhuhai Essex Bio-Pharmaceutical Co. Ltd ("Zhuhai Essex"), signed an amen
Propel Global Posts 2Q Revenue of RM24.5 Million
Propel Global Bhd
•
Feb 22, 2023 18:00 HKT/SGT
Propel Global Berhad, a provider of oil and gas (O&G) services as well as downstream specialty chemicals to the O&G industry, today announced that the Group recorded a 3.81% gain in revenue to RM24.5 million for the second quarter ended 31 December 2022 (2Q FY2023) compared with RM23.6 milli
HKTDC welcomes 2023-24 Budget
HKTDC
•
Feb 22, 2023 18:00 HKT/SGT
The Hong Kong Trade Development Council (HKTDC) welcomes the Hong Kong Special Administrative Region (HKSAR) 2023-24 budget, which allocates additional funding of HK$550 million over five years to the HKTDC to help Hong Kong enterprises seize opportunities arising from the Belt and Road Initiative (
QMC Receives Work Permit for Irgon Lithium Mine Project
QMC Quantum Minerals Corp
•
Feb 22, 2023 16:10 HKT/SGT
QMC Quantum Minerals Corp., (TSXV: QMC) (FSE: 3LQ) (OTC Pink: QMCQF) ("QMC" or "the Company") has received a work permit from the Government of Manitoba for the Company's Irgon Lithium Mine Property. The Irgon Lithium Mine has a historical resource estimate of 1.2 million to
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
Malaysian Genomics Resource Centre Bhd
•
Feb 22, 2023 14:30 HKT/SGT
Malaysian Genomics Resource Centre Bhd, a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a strategic collaboration agreement with Divine Genes Sdn Bhd to collaborate on business opportunities in relation to the improvement and international distribution
中滙集團公佈2023財年首三個月業務進展
Edvantage Group Holdings Limited
•
Feb 22, 2023 13:41 HKT/SGT
粵港澳大灣區最大的民辦商科高等及職業教育集團中滙集團控股有限公司（「中滙集團」或「集團」，股份代號：0382.HK）公佈截至2022年11月30日止三個月（「回顧期」）之未經審核財務以及業務進展的最新資料。業務進展亮點（截至2022年11月30日止三個月未經審計之相關數據）-- 收入同比增長19.9%至約471.8百萬元 （人民幣，下同）；-- 毛利同比增長20.9%至約238.0百萬元；-- 在校學生人數同比增加19.3%至約84,400人.內生增長持續穩定，學生人數持續上升於回顧期內，集團收入及毛利均錄得穩健增長。收入同比增長19.9%至約471.8百萬元；毛利同比增長20.9%至約238
Edvantage Group Announces Its Business Update for the First Three Months of FY2023
Edvantage Group Holdings Limited
•
Feb 22, 2023 13:40 HKT/SGT
Edvantage Group Holdings Limited ("Edvantage Group" or the "Group", stock code: 0382.HK), the largest private business higher and vocational education group in the Greater Bay Area, has announced its unaudited financial data and business update for the three months ended 30 Novem
BREATHE! Convention Releases Official White Paper, Detailing Mission on Web3 Adoption
ACN Newswire
•
Feb 22, 2023 09:30 HKT/SGT
Today, BREATHE! Convention announced the release of the official BREATHE! Convention White Paper (https://breatheconvention.com/white-paper/), which serves as a comprehensive guide that details a mission of rapidly increasing Web3 education and adoption around the world. "This is our love lette
Trescon's World Data & Analytics Show to propel Singapore businesses forward
ACN Newswire
•
Feb 22, 2023 07:29 HKT/SGT
World Data & Analytics Show is making its way to Singapore for its 5th global edition, bringing a spotlight on the ways data and analytics can bring value to businesses in the city-state. This gathering aims to highlight the latest developments and trends in the said field and demonstrate how or
Trintech Announces New Chief Revenue Officer
Trintech, Inc.
•
Feb 22, 2023 00:00 HKT/SGT
Trintech, a leading global provider of cloud-based financial close solutions for the Office of Finance, today announced the appointment of Piotr Marczewski as Chief Revenue Officer (CRO) of Trintech. Marczewski will be responsible for driving integration and alignment between revenue-related functio